K
Kenneth M. Heilman
Researcher at University of Florida
Publications - 712
Citations - 40917
Kenneth M. Heilman is an academic researcher from University of Florida. The author has contributed to research in topics: Neglect & Apraxia. The author has an hindex of 100, co-authored 706 publications receiving 39122 citations. Previous affiliations of Kenneth M. Heilman include Jerusalem Mental Health Center & McKnight Brain Institute.
Papers
More filters
Journal ArticleDOI
Factors in affective discrimination of speech
TL;DR: Surgical intervention should be attempted in all cases, even when the prognostic indicators all point to a poor outcome, as in the cases of children with spontaneous cerebellar hemorrhages who survived even though they were in extremis on admission to the hospital.
Journal ArticleDOI
Musical hallucinations with a right frontotemporal stroke
TL;DR: A patient who in the absence of these disorders developed musical hallucinations from an infarction of the right hemisphere that primarily injured his right frontal and anterior temporal lobes is presented.
Journal Article
Perceptual Pseudoneglect: Laterality and the Perception of Tactile Pressure (P4.056)
Tigran Kesayan,Tigran Kesayan,Damon G. Lamb,John B. Williamson,Adam D. Falchook,Kenneth M. Heilman +5 more
TL;DR: Heilman et al. as mentioned in this paper found that the right hand perceived stimuli that were lighter than the standard stimulus to be more intense than when these same stimuli were perceived by the left hand.
Journal ArticleDOI
Feeling and Looking Down: Impact of Depressive Symptoms on the Allocation of Vertical Attention.
TL;DR: Depressive symptoms may be associated with a relative lowering of the vertical attentional bias, and this lowering may be related to increased activation of portions of the default network.
Journal ArticleDOI
The Correlation between Sleep and Creativity
Valeria Drago,Debora Aricò,Kenneth M. Heilman,Paul S. Foster,John B. Williamson,Pasquale Montagna,Raffaele Ferri +6 more
TL;DR: This research presents a novel and scalable approach called “SmartLabeling” that allows for real-time monitoring of the physical and emotional changes in the brain during the development of Alzheimer’s disease.